Cvs Health (CVS) Liabilities and Shareholders Equity (2009 - 2026)

Cvs Health (CVS) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $253.0 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 1.02% year-over-year to $253.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1020.2 billion (up 0.64% YoY) and the FY2025 annual result came in at $253.5 billion, changed 0.13% from the prior year.
• Liabilities and Shareholders Equity held at $253.0 billion in Q1 2026, from $253.5 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $258.3 billion in Q2 2025 to a low of $228.3 billion in Q4 2022.
• A 5-year average of $246.9 billion and a median of $251.3 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity slipped 2.03% — and 2023, when it climbed 9.4%.
• Tracing CVS's Liabilities and Shareholders Equity over 5 years: stood at $228.3 billion in 2022, then advanced by 9.4% to $249.7 billion in 2023, then gained by 1.4% to $253.2 billion in 2024, then grew by 0.13% to $253.5 billion in 2025, then decreased by 0.22% to $253.0 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $253.0 billion (Q1 2026), $253.5 billion (Q4 2025), and $255.3 billion (Q3 2025), per Business Quant data.